ATEZOLIZUMAB for Bladder cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 487 adverse event reports in the FDA FAERS database where ATEZOLIZUMAB was used for Bladder cancer.
Most Reported Side Effects for ATEZOLIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 3,591 | 10.7% | 3,591 | 457 |
| Off label use | 2,340 | 6.9% | 769 | 611 |
| Disease progression | 1,828 | 5.4% | 815 | 355 |
| Pyrexia | 1,599 | 4.7% | 261 | 1,096 |
| Diarrhoea | 1,490 | 4.4% | 327 | 798 |
| Fatigue | 1,253 | 3.7% | 296 | 504 |
| Anaemia | 1,195 | 3.6% | 237 | 695 |
| Pneumonia | 1,036 | 3.1% | 382 | 698 |
| Nausea | 953 | 2.8% | 219 | 498 |
| Dyspnoea | 938 | 2.8% | 290 | 614 |
| Decreased appetite | 928 | 2.8% | 233 | 436 |
| Hypothyroidism | 881 | 2.6% | 114 | 202 |
| Febrile neutropenia | 872 | 2.6% | 148 | 641 |
| Pneumonitis | 842 | 2.5% | 243 | 416 |
| Asthenia | 821 | 2.4% | 262 | 389 |
Other Indications for ATEZOLIZUMAB
Hepatocellular carcinoma (8,443)
Non-small cell lung cancer (4,459)
Small cell lung cancer (2,107)
Product used for unknown indication (1,888)
Small cell lung cancer extensive stage (1,398)
Triple negative breast cancer (1,393)
Lung neoplasm malignant (1,262)
Lung adenocarcinoma (1,032)
Non-small cell lung cancer metastatic (870)
Transitional cell carcinoma (788)
Other Drugs Used for Bladder cancer
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279)
PEMBROLIZUMAB (869)
GEMCITABINE (841)
CISPLATIN (780)
ENFORTUMAB VEDOTIN-EJFV (530)
NIVOLUMAB (512)
CARBOPLATIN (332)
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326)
GEMCITABINE\GEMCITABINE (240)
ENFORTUMAB VEDOTIN (225)